Assessing Drug Interactions and Pharmacogenomics in Patients on Warfarin 
While anticoagulation is life-saving in the management of patients with venous thromboembolic disease, anticoagulation, most especially with warfarin, is associated with one of the highest rates of preventable adverse events as highlighted in the National Action Plan for Adverse Drug Event Prevention. Read more.

Spotlighting COVID-19-Related Cytokine Storm Syndrome
It is well known that a subset of patients infected with COVID-19 progress to exhibit cytokine storm syndrome. As this pandemic continues to evolve and the full spectrum of clinical manifestations of COVID-19 come to light, knowledge about the presentation and management of other hematological cytokine storm syndromes may help the pharmacist manage these critically ill patients. Read more.

Role of Anti–CD20 Therapy in Follicular and Marginal Zone Lymphomas
CD20, a transmembrane B-cell differentiation antigen, is expressed in both healthy (late pre-B and mature B-cells) as well as in malignant B-cells and plays a role in the development of B-cells into plasma cells. A recent review examined the role that anti–CD20 therapy plays in the management of follicular lymphoma and marginal zone lymphoma. Read more.